STOCK TITAN
  1. Home
  2. Sec-filings
  3. TEVA
  4. [ARS] TEVA PHARMACEUTICAL INDUSTRIES LTD SEC Filing

[ARS] TEVA PHARMACEUTICAL INDUSTRIES LTD SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
ARS
ARS - TEVA PHARMACEUTICAL INDUSTRIES LTD

ARS Filing - TEVA PHARMACEUTICAL INDUSTRIES LTD

This filing is available as a PDF document.

Filing Type: ARS

Company: TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)

Acceptance Date: 2026-03-31T16:41:07.000Z

View PDF Document

Source: View Original Filing on SEC EDGAR

Teva Pharm

NYSE:TEVA

View TEVA Stock Overview →

TEVA Rankings

#408 Ranked by Market Cap
N/A Ranked by Dividends
#153 52-Week Gainer
#1332 YTD Gainer
#1752 Monthly Gainer
#126 Ranked by Short %Change

TEVA Latest News

Mar 30, 2026
Teva Gains Biosimilar Momentum with U.S. FDA Approval of PONLIMSI™ (denosumab-adet) and Dual Filing Acceptance for Biosimilar Candidate to Xolair® (omalizumab)
Mar 19, 2026
Teva to Host Conference Call to Discuss First Quarter 2026 Financial Results at 8 a.m. ET on April 29, 2026
Mar 19, 2026
Teva Releases Q1 2026 Aide Memoire
Mar 3, 2026
Teva and Blackstone Life Sciences Announce $400 Million Strategic Growth Capital Agreement to Advance duvakitug
Feb 24, 2026
Teva to Present at the Upcoming Investor Conferences in March

TEVA Latest SEC Filings

Mar 31, 2026
[DEF 14A] TEVA PHARMACEUTICAL INDUSTRIES LTD Definitive Proxy Statement
Mar 19, 2026
[Form 4] TEVA PHARMACEUTICAL INDUSTRIES LTD Insider Trading Activity
Mar 17, 2026
[144] TEVA PHARMACEUTICAL INDUSTRIES LTD SEC Filing
Mar 9, 2026
[Form 4] TEVA PHARMACEUTICAL INDUSTRIES LTD Insider Trading Activity
Mar 9, 2026
[Form 4] TEVA PHARMACEUTICAL INDUSTRIES LTD Insider Trading Activity

TEVA Stock Data

33.02B
1.16B
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
Israel
TEL AVIV